Literature DB >> 3379306

An immunogenic antigen of murine Plasmodium yoelii 17X associates with class I MHC glycoproteins.

R J Mogil1, C L Patton, D R Green.   

Abstract

Reticulocytes infected with the non-lethal variant of Plasmodium yoelii 17X (PY17X-NL) express elevated levels of class I, but not class II, MHC Ag when compared with non-parasitized reticulocytes. In contrast, class I Ag are not detectable on erythrocytes parasitized by the lethal variant PY17X-L. In addition, the responder status of various inbred strains of mice to PY17X-NL has been shown to positively correlate with the levels of class I MHC antigens expressed on PY17X-NL parasitized red blood cells (PRBC). MHC Ag are known to restrict, or guide, immune responses. However, earlier studies have failed to demonstrate H-2 restricted activity in the effector arm of immunity to blood-stage murine malaria. Therefore, we have examined the induction of immunity by irradiated PY17X-NL PRBC. No MHC restriction was observed in the ability of PRBC to immunize recipients. However, using irradiated PRBC bearing low, intermediate or high levels of class I Ag we found that the levels, rather than haplotype, of class I Ag expressed on irradiated PRBC greatly influenced their ability to induce immunity. Furthermore, class I-associated parasite-directed Ag were isolated as an immunogenic complex with anti-class I MHC antibody. Such complexes induced immunity in vivo in the absence of adjuvant suggesting a biologically important mechanism by which non-lethal, reticulocytic forms of malarial parasites may immunize their hosts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379306

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  1 in total

1.  Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage.

Authors:  Natália Satchiko Hojo-Souza; Patrick Orestes de Azevedo; Júlia Teixeira de Castro; Andréa Teixeira-Carvalho; Judy Lieberman; Caroline Junqueira; Ricardo Tostes Gazzinelli
Journal:  PLoS Pathog       Date:  2020-09-10       Impact factor: 7.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.